The tau pathology in the STZ rodent model of dementia is preceded by early changes in the phosphatidylinositol-3-kinase (i.e., PI3K, phospho-Akt, GSK-3β) insulin/IGF-signaling pathway [137]. This evidence concerns the gene MAPT and dementia.